Esteve

Patent cliffs & loss of exclusivity

1 upcoming patent cliff

DrugIngredientTypeCliff
  1. QUZYTTIRCETIRIZINE HYDROCHLORIDESmall mol.Feb 2030
  2. METOPIRONEMETYRAPONESmall mol.
  3. PRIALTZICONOTIDE ACETATESmall mol.
  4. PRIALTZICONOTIDE ACETATESmall mol.
  5. PRIALTZICONOTIDE ACETATESmall mol.
  6. PRIALTZICONOTIDE ACETATESmall mol.
  7. LYSODRENMITOTANESmall mol.
  8. METOPIRONEMETYRAPONESmall mol.

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.